In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
World Health Organization - WHO
Brigham and Women's Hospital, Division of Global Health Equity
FYI and apologies for cross-posting ---------- Forwarded message ---------- From: HMS-Sentinel Project Date: Mon, Mar 2, 2015 at 9:54 AM Subject: Invitation to: MDR-TB Elimination in Chuuk: A Case for Treating LTBI To:…
[Please forward widely & excuse cross-posting] Call to action: Accelerate access to DR-TB drugs Médecins Sans Frontières (MSF), RESULTS UK, SWIFT, Treatment Action Campaign (TAC), Treatment Action Group (TAG) and others are calling on global health actors…
Lancet Infectious Disease just published an interesting opinion piece on what can be learned after the four recent negative trials on the use of fluoroquinolone containing regimens to shorten TB treatment. I have attached that piece to this post. The…
Dorcas Naa Dedei Aryeetey
International Federation of Medical Students' Associations - IFMSA